Jefferies Raises Chemed to Buy, Target to $620 from $520
Jefferies raised its rating on Chemed to Buy from Hold and its price target to $620 from $520.
Related stories
Shanghai Composite Falls Below 3,600 in Morning Trading
L impact | EQUITY | Oct 30, 2026, 01:31 AM UTC
Timberland Bancorp Q4 Earnings Snapshot
Timberland Bancorp reported net income for its fiscal fourth quarter.
M impact | EQUITY | Oct 30, 2026, 01:31 AM UTC
Asian session market picture: S&P 500 -0.99%, Nasdaq 100 -2.3%; USD/JPY -0.19%, WTI +0.77%, 1810 leads volume
Asian session market picture. US index futures: S and P futures is down 0.99 percent, Nasdaq futures is down 2.3 percent, Dow futures is down 0.14 percent and Russell futures is do
M impact | EQUITY | Oct 30, 2026, 01:30 AM UTC
Rent.com.au Reports Quarterly Group Revenue of A$1.53 Million
M impact | EQUITY | Oct 30, 2026, 01:29 AM UTC
HanmiGlobal Wins 59.5 Billion Won Order
M impact | EQUITY | Oct 30, 2026, 01:29 AM UTC
Eoptolink opens 12.4% lower
Chinese optical-module producer Eoptolink opened 12.4% lower.
M impact | EQUITY | Oct 30, 2026, 01:29 AM UTC